Ami Organics Ltd
Ami Organics Limited is one of the leading research and development-driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, and materials for agrochemicals and fine chemicals.[1]
- Market Cap ₹ 4,533 Cr.
- Current Price ₹ 1,229
- High / Low ₹ 1,389 / 1,004
- Stock P/E 69.1
- Book Value ₹ 170
- Dividend Yield 0.25 %
- ROCE 20.9 %
- ROE 15.2 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 35.5% CAGR over last 5 years
Cons
- Stock is trading at 7.29 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|
160 | 188 | 236 | 240 | 341 | 520 | 617 | 654 | |
137 | 158 | 193 | 198 | 259 | 415 | 493 | 546 | |
Operating Profit | 23 | 31 | 43 | 42 | 81 | 105 | 124 | 108 |
OPM % | 14% | 16% | 18% | 18% | 24% | 20% | 20% | 17% |
0 | 3 | 1 | 2 | 0 | 3 | 3 | -27 | |
Interest | 3 | 3 | 5 | 6 | 6 | 6 | 2 | 4 |
Depreciation | 1 | 2 | 3 | 4 | 4 | 10 | 12 | 14 |
Profit before tax | 19 | 28 | 37 | 35 | 72 | 91 | 112 | 63 |
Tax % | 35% | 35% | 33% | 21% | 25% | 21% | 26% | |
12 | 18 | 25 | 27 | 54 | 72 | 83 | 39 | |
EPS in Rs | 80.33 | 122.87 | 23.46 | 26.16 | 17.14 | 19.75 | 22.87 | 10.66 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 15% | 13% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 27% |
3 Years: | 37% |
TTM: | 14% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 35% |
3 Years: | 44% |
TTM: | -15% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 14% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 22% |
3 Years: | 20% |
Last Year: | 15% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 2 | 2 | 10 | 10 | 32 | 36 | 36 | 37 |
Reserves | 38 | 56 | 71 | 97 | 132 | 482 | 550 | 589 |
26 | 41 | 54 | 59 | 137 | 1 | 3 | 99 | |
43 | 56 | 77 | 61 | 110 | 136 | 169 | 221 | |
Total Liabilities | 109 | 155 | 212 | 228 | 410 | 655 | 759 | 946 |
14 | 15 | 58 | 62 | 161 | 178 | 222 | 232 | |
CWIP | 11 | 30 | 2 | 12 | 0 | 3 | 30 | 92 |
Investments | 15 | 21 | 28 | 28 | 33 | 33 | 33 | 70 |
68 | 89 | 124 | 126 | 216 | 440 | 474 | 551 | |
Total Assets | 109 | 155 | 212 | 228 | 410 | 655 | 759 | 946 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|
29 | 10 | 22 | 27 | 27 | -10 | 56 | |
-19 | -27 | -25 | -24 | -101 | -122 | -20 | |
-7 | 14 | 3 | 0 | 72 | 140 | -14 | |
Net Cash Flow | 2 | -2 | -0 | 3 | -2 | 8 | 21 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|
Debtor Days | 83 | 97 | 113 | 80 | 127 | 113 | 136 |
Inventory Days | 76 | 89 | 95 | 148 | 123 | 150 | 131 |
Days Payable | 148 | 154 | 168 | 146 | 172 | 158 | 157 |
Cash Conversion Cycle | 11 | 31 | 40 | 83 | 78 | 105 | 111 |
Working Capital Days | 46 | 59 | 63 | 80 | 117 | 139 | 148 |
ROCE % | 38% | 35% | 27% | 33% | 24% | 21% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2m - Newspaper Publication of the Postal Ballot notice of the Company is herewith attached.
-
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
1d - Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 as per details attached.
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 1d
-
Announcement under Regulation 30 (LODR)-Preferential Issue
2d - Issuance of equity shares on preferential basis as per the details attached.
- Board Meeting Outcome for Outcome Of The Board Meeting Held On April 26, 2024 - Approval For Issuance Of Equity Shares On Preferential Basis 2d
Annual reports
Concalls
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Oct 2021Transcript PPT
Business Overview
AMI Organics is a manufacturer of specialty chemicals with varied end usage and is focused on the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic APIs and New Chemical Entities (NCE) and key starting material for agrochemical and fine chemicals. It has developed and commercialized over 520 products across 50 countries, supplied to over 500 customers. [1]